To uphold transparency and patient confidence, we are readily making these reports publicly available
doi: 10.1055/s-0044-1779508
Our providers will recommend the best treatment plan for safe, effective results
"And remember these are associations, not causations, so it's not to say that GLP-1 use causes NAION or worsening retinopathy, but their use is associated with these conditions." "From an ophthalmologic standpoint, these findings underscore the importance of baseline and follow-up eye examinations for patients starting GLP-1 therapy, especially those with pre-existing retinal or optic nerve risk factors." The expert added that while the benefits of GLP-1 medications in reducing cardiovascular and metabolic risks are "substantial," patients should be counseled on potential visual side effects, and "any sudden visual symptoms should prompt immediate ophthalmic referral." For more Health articles, visit www.foxnews.com/health Novo Nordisk, maker of Ozempic and Wegovy, provided the following statement when contacted by Fox News Digital
Dosage : Review the dosage per serving and how many servings are recommended
Q6: Should I use a pre-blended vial or separate vials
